NPC1-like phenotype, with intracellular cholesterol accumulation and altered mTORC1 signaling in models of Parkinson's disease
Authors:
Open Access
- 5 December 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1870 (2) , 166980
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (PTDC/MEDFSL/30104/2017)
- Swedish Research Council
This publication has 64 references indexed in Scilit:
- Oligomycin frames a common drug-binding site in the ATP synthaseProceedings of the National Academy of Sciences, 2012
- Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent trafficHuman Molecular Genetics, 2012
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome HomeostasisScience Signaling, 2012
- A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEBThe EMBO Journal, 2012
- Analysis of Cholesterol Trafficking with Fluorescent Probes2012
- Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cellsJournal of Clinical Investigation, 2011
- Monitoring Mitophagy in Neuronal Cell Cultures2011
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009